KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fulgent Genetics (FLGT) Interest Expenses (2023 - 2025)

Fulgent Genetics (FLGT) has disclosed Interest Expenses for 3 consecutive years, with $16000.0 as the latest value for Q4 2025.

  • Quarterly Interest Expenses fell 60.0% to $16000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $75000.0 through Dec 2025, up 144.12% year-over-year, with the annual reading at $75000.0 for FY2025, 144.12% up from the prior year.
  • Interest Expenses hit $16000.0 in Q4 2025 for Fulgent Genetics, down from $28000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $70000.0 in Q3 2023 to a low of -$249000.0 in Q1 2024.
  • Historically, Interest Expenses has averaged -$16200.0 across 3 years, with a median of $16500.0 in 2025.
  • Biggest YoY gain for Interest Expenses was 129.2% in 2024; the steepest drop was 80.0% in 2024.
  • Year by year, Interest Expenses stood at -$137000.0 in 2023, then surged by 129.2% to $40000.0 in 2024, then tumbled by 60.0% to $16000.0 in 2025.
  • Business Quant data shows Interest Expenses for FLGT at $16000.0 in Q4 2025, $28000.0 in Q3 2025, and $17000.0 in Q2 2025.